What Supporters Are Saying

Our coalition is united in support of Prop 38 to advance life-saving immunology research to prevent and cure debilitating diseases like cancer, Alzheimer’s and heart disease.

"Prop 38 is a meaningful opportunity to advance the science that could prevent and cure Alzheimer's disease. Immunology research is helping unlock how the brain and immune system interact — knowledge critical to the next generation of treatments. The Alzheimer's Association urges Californians to vote yes in November." 

Ken Toren
Executive Director in Northern California
Alzheimer’s Association/AIM

"As a mother navigating my son's journey through leukemia treatment and now a complex, unexplained immune condition, I've seen both the promise and the gaps in immunology. Families like ours need more treatments, more breakthroughs, and more hope. Prop 38 gives families like ours a fighting chance, not just against cancer, but against everything that comes after."

Bhavika Taunk
Bhavika Taunk
Mother & Advocate for Childhood Cancer Survivors

“Immunotherapy is saving lives today, but continued investment is critical to reach more patients and accelerate tomorrow's cures.”

Dr. Michael Constantinides, Ph.D.
Dr. Michael Constantinides, Ph.D.
Associate Professor at Scripps Research

"As a researcher whose work has been impacted by funding cuts, I know firsthand that sustained investment in immunology is essential to delivering the next generation of lifesaving treatments."

Dr. Jillian McCool, Ph.D. in Quantitative and Systems Biology 
Dr. Jillian McCool, Ph.D. in Quantitative and Systems Biology 

"Immunotherapy saved my life — I was just weeks away from losing my life when a breakthrough treatment gave me a second chance. That’s why I’m proud to support Prop 38, because no one should be told hope is out of reach when we have the science to save them."

Laurie Adami
Laurie Adami
Cancer Pioneer and Patient Advocate

“Medical research gives people living with ALS something we urgently need: more time, more hope and more chances for breakthroughs.”

Jessy Ybarra
Jessy Ybarra
Air Force Veteran, Person Living with ALS & ALS Advocate

"Immunotherapies are an incredible medical innovation that has extended the lives of kidney cancer patients. I believe the onslaught of promising treatments on the horizon will most definitely have an even greater impact on kidney cancer patients and their families in the future. Our goal is to keep up the momentum through continued research in hopes of saving even more lives."

Gretchen E. Vaughan
President and CEO
Kidney Cancer Association

"Immunology research is transforming how we prevent and treat diseases from Alzheimer's and diabetes to cancer. Prop 38 will help advance discoveries that lead to better treatments, diagnostics and life-saving cures."

Dr. Shane Crotty, Ph.D.
Dr. Shane Crotty, Ph.D.
Professor & Chief Scientific Officer
La Jolla Institute for Immunology

“I’m alive today because of the researchers and doctors who found an immunotherapy that cured my cancer. Prop 38 will expand research and lifesaving cures to save the lives of even more patients like me.”

Andrew Dale
Andrew Dale
Immunotherapy Patient and Cancer Survivor

“Scientific breakthroughs don’t happen by chance. With Prop 38, California can turn cutting-edge discoveries into real treatments faster, giving patients new hope and ensuring the state leads in developing the next wave of cures.”

Dr. Arie Belldegrun, M.D.
Dr. Arie Belldegrun, M.D.
Leader in Life-Saving Cancer Immunotherapies; UCLA Research Professor of Urology

“Prop 38 can accelerate lifesaving innovation, strengthen America’s leadership in biomedical research and bring new therapies to patients who cannot afford to wait.”

Dr. Babak Kateb, M.D., Ph.D.
Dr. Babak Kateb, M.D., Ph.D.
Chairman of the Board & CEO
Society for Brain Mapping and Therapeutics

“Prop 38 will empower the next generation of scientists to pursue breakthrough research that can lead to new treatments and cures for some of the most serious diseases facing our society.”

Dr. Samuel Broder, M.D.
Dr. Samuel Broder, M.D.
Former Director, National Cancer Institute
Member, National Academy of Medicine

“California has long been a global leader in scientific innovation, and we cannot afford to slow progress. Immunotherapy is opening extraordinary new possibilities not only for cancer, but also for Alzheimer’s disease and neurological disorders, and California will lead the world toward lifesaving breakthroughs.”

Dr. Vicky Yamamoto, Ph.D.
Founding Member of the World Brain Mapping Foundation

"Immunotherapy is changing the future of cancer care, but patients can’t afford for research to slow down. We urgently need sustained investment to accelerate breakthroughs and bring more life-saving treatments to patients and families.”

Gina Carithers
President and CEO
Prostate Cancer Foundation

“Substantially more public investment in immunology research is needed to understand the full potential of reprogramming the immune system to cure a broad range of diseases. Prop 38 promises to do just that.”

Dr. Keith Flaherty, M.D.
Dr. Keith Flaherty, M.D.
Leading Medical Oncologist

“Advances in immunology are opening new doors to slowing or stopping neurodegenerative diseases. Prop 38 is an investment in hope and promising scientific progress for the Frontotemporal Degeneration community." 

Meghan Buzby
Director of Advocacy & Volunteer Engagement
The Association for Frontotemporal Degeneration

“When I was diagnosed with stage 4 kidney cancer, I thought my life was over, but immunotherapy has given my family hope for the future, and perhaps a chance at a full life. Having worked in scientific research, I understand the promise these breakthroughs hold and strongly believe we must continue investing in immunotherapy research so more families can have the same hope and lives can be saved.”

Byron Olsen
Byron Olsen
Scientist and Kidney Cancer Patient

“Immunology research is essential to advancing new ways to prevent, detect, and treat liver disease and liver cancer. Prop 38 accelerates the development of life‑saving treatments that strengthen the immune system and bring promising cures closer to the families most affected.”

Scott A. Suckow
Executive Director
Liver Coalition

"I support immunology and immunotherapy research because it is one of the few levers we have that can fundamentally change the trajectory of cancer and many immune‑driven diseases in a single generation."

Ignacio Baselga
Clinical Trial Lead at UCLA

"Having spent decades at the forefront of disease prevention, I understand the promise of vaccines, therapies and cures that come from immunology research. Prop 38 is a vital step toward decoding the human immune system and accelerating the breakthroughs needed to end our most devastating diseases."

Dr. Wayne Koff, Ph.D., Founding CEO
Dr. Wayne Koff, Ph.D., Founding CEO
Human Immunome Project

"As a cancer survivor, and someone who has lost many family members to cancer and other diseases like heart disease, I believe investing in immunology and immunotherapy research is where the promise resides in new therapies and cures for a myriad of diseases."

John Baker
Vice President of Philanthropy at City of Hope

"As a Professor of Immunology at UCLA and leader of the Yang Engineering Immunity Lab, I develop immunotherapies for cancer, autoimmune disorders, Alzheimer’s, Parkinson’s and heart disease. With declining federal research funding, Prop 38 is essential to sustaining innovation and accelerating life-saving treatments for patients across California."

Dr. Lili Yang, Ph.D.
Professor of Microbiology, Immunology and Molecular Genetics at UCLA

"At a time of declining federal research funding, I support Prop 38 because it will provide sustained support to accelerate innovation and the development of transformative immunotherapies. Prop 38 is essential to ensuring scientific advances can be translated into life-saving treatments that improve outcomes for patients across California."

Yichen Zhu
Graduate Student at UCLA

“Amid growing uncertainty in public health, healthcare access, and research funding, California cannot afford to fall behind. Prop 38 is critical to keeping our state at the forefront of lifesaving innovation and protecting the health and wellbeing of our communities.”

Marketa Houskova
CEO of American Nurses Association/California

“Immunology and immunotherapy research represents one of the most transformative frontiers in modern medicine.”

Dr. Linda Liau, M.D., Ph.D., MBA
Dr. Linda Liau, M.D., Ph.D., MBA
Professor & Chair of Neurosurgery at UCLA David Geffen School of Medicine

“Emerging insights from immunology are reshaping how we understand ALS and where new treatments may come from. Prop 38 is a critical step toward accelerating research that can meaningfully slow disease progression. For people living with ALS, time is the one thing they don’t have, making action like this not just important, but imperative.” 

Melanie Lendnal, Senior Vice President, Policy & Advocacy
The ALS Association

"The immune system holds one of the most promising pathways to curing diseases that have long evaded treatment. Major initiatives are needed to turn that emerging science into real-world solutions faster — bringing us closer to therapies that save lives."

Dr. Elaine Y. Hsiao, Ph.D.
Dr. Elaine Y. Hsiao, Ph.D.
Professor & Leading Immunology and Brain Health Researcher

"Blood Cancer United strongly supports Prop 38. This measure will strengthen California’s research and clinical trial infrastructure, helping patients access cutting-edge therapies sooner while accelerating the search for cures."

Adam Zarrin, Director of State Gov. Affairs
Blood Cancer United

"The Parkinson Association of Northern California supports Prop 38 because it drives disease-modifying research focused on slowing or stopping Parkinson’s, not just managing its symptoms. This work advances our understanding of the gut-immune-brain connection, where the disease may originate, and holds real potential to save lives.”

Jan Whitney, Executive Director
Parkinson Association of Northern California

"We stand at a threshold of exciting breakthroughs in treating intractable diseases. We need to support cure-finding research in immunology and immunotherapies."

Dr. Steve A. Kay, Ph.D., D.Sc., FRS
Dr. Steve A. Kay, Ph.D., D.Sc., FRS
Professor and Director, University of Southern California; Member, National Academy of Sciences

"We believe California should lead the nation in science funding, and Prop 38 is a prime example of how strategic investment can improve the health outcomes of all Californians."

Dr. Margaret Hitchcock, Ph.D., President
California Colorectal Cancer Coalition

"Immunology research is our most powerful tool for preventing and curing diseases ranging from cancer to Alzheimer's. Prop 38 will accelerate lifesaving discoveries, strengthen our preparedness for future health threats and deliver hope to millions of families."

Dr. Peter Hotez, M.D., Ph.D.
Dr. Peter Hotez, M.D., Ph.D.
Pediatrician and Vaccine Scientist

"Prop 38 is an important part of the equation to help close the gap in health outcomes for black Californians and other vulnerable communities."

Rhonda Smith, Executive Director
California Black Health Network

*Partial list

Titles and affiliations are for identification purposes only.